Share-based Payment Arrangement, Expense of Panbela Therapeutics, Inc. from 31 Mar 2014 to 31 Mar 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Panbela Therapeutics, Inc. quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 31 Mar 2014 to 31 Mar 2024.
  • Panbela Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending 31 Mar 2024 was $103,000, a 43% decline year-over-year.
  • Panbela Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $823,000, a 24% decline from 2022.
  • Panbela Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $1,088,000, a 15% decline from 2021.
  • Panbela Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $1,287,000, a 6.8% increase from 2020.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

Panbela Therapeutics, Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2024 $103,000 -$77,000 -43% 01 Jan 2024 31 Mar 2024 10-Q 15 May 2024 2024 Q1
Q1 2023 $180,000 -$154,000 -46% 01 Jan 2023 31 Mar 2023 10-Q 15 May 2024 2024 Q1
Q1 2022 $334,000 +$82,000 +33% 01 Jan 2022 31 Mar 2022 10-Q 04 May 2023 2023 Q1
Q1 2021 $252,000 +$140,000 +125% 01 Jan 2021 31 Mar 2021 10-Q 12 May 2022 2022 Q1
Q1 2020 $112,000 +$102,000 +1020% 01 Jan 2020 31 Mar 2020 10-Q 12 May 2021 2021 Q1
Q1 2019 $10,000 -$1,782,000 -99% 01 Jan 2019 31 Mar 2019 10-Q 12 May 2020 2020 Q1
Q1 2018 $1,792,000 +$872,000 +95% 01 Jan 2018 31 Mar 2018 10-Q 14 May 2019 2019 Q1
Q1 2017 $920,000 +$845,000 +1127% 01 Jan 2017 31 Mar 2017 10-Q 14 May 2018 2018 Q1
Q1 2016 $75,000 +$33,000 +79% 01 Jan 2016 31 Mar 2016 10-K 21 Mar 2018 2017 FY
Q1 2015 $42,000 -$49,000 -54% 01 Jan 2015 31 Mar 2015 10-K 30 Mar 2017 2016 FY
Q1 2014 $91,000 01 Jan 2014 31 Mar 2014 10-K 08 Mar 2016 2015 FY

Panbela Therapeutics, Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2023 $823,000 -$265,000 -24% 01 Jan 2023 31 Dec 2023 10-K 26 Mar 2024 2023 FY
2022 $1,088,000 -$199,000 -15% 01 Jan 2022 31 Dec 2022 10-K 26 Mar 2024 2023 FY
2021 $1,287,000 +$82,000 +6.8% 01 Jan 2021 31 Dec 2021 10-K 16 Mar 2023 2022 FY
2020 $1,205,000 01 Jan 2020 31 Dec 2020 10-K 24 Mar 2022 2021 FY
2018 $263,000 -$232,000 -47% 01 Jan 2018 31 Dec 2018 10-K 22 Mar 2019 2018 FY
2017 $495,000 -$62,000 -11% 01 Jan 2017 31 Dec 2017 10-K 22 Mar 2019 2018 FY
2016 $557,000 +$487,000 +696% 01 Jan 2016 31 Dec 2016 10-K 21 Mar 2018 2017 FY
2015 $70,000 +$44,000 +169% 01 Jan 2015 31 Dec 2015 10-K 30 Mar 2017 2016 FY
2014 $26,000 01 Jan 2014 31 Dec 2014 10-K 08 Mar 2016 2015 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.